InnovAge Holding Corp. (INNV) stock
INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3063% above fair value
$9.42−0.16 (-1.67%)
Close on Nov 17, 2026Market cap $1.29BP/E –Yield –
InnovAge operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
InnovAge's operating cash flow for the twelve months ending Jun 30, 2026 was $64.71M, up 96.9% year over year. For fiscal 2026 it was $64.71M, up 96.9% from the year before. The highest annual figure on record is $64.71M in fiscal 2026.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $64.71M | +96.9% |
| FY2025 | Jun 30, 2025 | $32.87M | – |
| FY2024 | Jun 30, 2024 | -$36.90M | -282.3% |
| FY2023 | Jun 30, 2023 | $20.24M | -25.9% |
| FY2022 | Jun 30, 2022 | $27.30M | – |
| FY2021 | Jun 30, 2021 | -$7.55M | -117.2% |
| FY2020 | Jun 30, 2020 | $43.83M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $21.29M | +136.5% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $18.14M | -26.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $21.36M | +216.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $3.92M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $9.00M | +380.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $24.63M | +602.1% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $6.75M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$7.52M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $1.87M | -85.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $3.51M | -87.9% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$9.29M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$32.99M | -351.3% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $13.15M | +305.5% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $29.08M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$35.12M | -418.7% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $13.13M | -36.1% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $3.24M | -65.8% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$7.52M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $11.02M | -36.4% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $20.56M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $9.48M | -60.2% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$16.29M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $17.32M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$18.06M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $23.81M | – |
See a number that looks wrong?